Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
The Oncologist|November 22, 2018
Association of Modified-FOLFIRINOX-Regimen-Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese PopulationXiang Li, Chengxiang Guo, Qinghai Li, et al.Xenotransplantation|April 29, 2026
Integrated Multi-Omics Analysis of Coagulation Dysregulation and Immune Pathway Alterations in 10-Gene Pig-to-Monkey Liver Xenotransplantation: A Case ReportWei Zhang, Rongrong Wang, Xuan Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|August 7, 2023
The liquid-to-solid transition of FUS is promoted by the condensate surfaceYi Shen, Anqi Chen, Wenyun Wang, et al.Journal of Medical Virology|August 31, 2022
VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenesYinan Shen, Wei Song, Danni Lin, et al.Cell Reports. Medicine|July 31, 2025
BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastomaChen Guo, Zhilin Long, Peng Lin, et al.Physical Review Letters|September 17, 2021
Effects of Vimentin Intermediate Filaments on the Structure and Dynamics of In Vitro Multicomponent Interpenetrating Cytoskeletal NetworksYinan Shen, Huayin Wu, Peter J Lu, et al.Gut|July 13, 2021
Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogenyJianpeng Sheng, Junlei Zhang, Lin Wang, et al.Nature|July 15, 2026
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinomaQi Zhang, Qihan Fu, Yinan Shen, et al.Nature|March 20, 2025
Oncolytic virus VG161 in refractory hepatocellular carcinomaYinan Shen, Xueli Bai, Qi Zhang, et al.Pageof 5